Akkaraju Srinivas's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Jan 25, 2022
- Accession no.
- 0001209191-22-004735
- Filed
- Jan 25, 2022, 2:30 PM ET
- Trade date
- Jan 21-24, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.10M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Akkaraju SrinivasCIK 0001253170 | 10% Owner |
| Samsara BioCapital, L.P.CIK 0001699737 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2022 | Common Stock | PPurchaseAcquired | +100,000 | $8.99 | +$899,000 | 8,011,850 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +23,000 | $8.70 | +$200,100 | 8,034,850 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.